Small molecule · Inhibitor of Cyclooxygenase-2 (PTGS2) · developed by Gd Searle Llc
ApprovedFDA, Dec 1999
1Registered trials
What is Celecoxib?
Celecoxib is a nonsteroidal anti-inflammatory drug that inhibits prostaglandin synthesis, primarily by inhibiting COX-2, reducing prostaglandin-mediated pain and inflammation in peripheral tissues. It is studied in osteoarthritis.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Jul 31, 2025). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.